M
Metlen Energy & Metals MTLN.L · GBp
Industrials · Industrial Conglomerates · LSE · 🇬🇧 United Kingdom
FTSE 100
44.50p
-0.13%
Close of 6 Nov 2026, in pence
At a glance
Figures in EUR, from our data supplier.
Revenue
€7.11bn
FY2016FY2025
Net income
€314.5m
FY2016FY2025
Free cash flow
−€241.7m
FY2016FY2025
Shareholders' equity
€3.01bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €7.11bn | €5.68bn | €5.49bn | €6.31bn | €2.66bn | €1.90bn | €2.25bn | €1.53bn | €1.53bn | €1.25bn |
| Gross profit | €464.2m | €1.02bn | €980.0m | €963.2m | €365.8m | €339.7m | €341.3m | €303.0m | €327.8m | €221.7m |
| Research and development | — | — | €63,000 | €171,000 | €274,968 | €259,272 | €257,824 | €137,951 | €139,338 | €136,935 |
| Operating income | €544.5m | €884.1m | €905.3m | €743.9m | €278.6m | €216.9m | €218.7m | €216.0m | €243.3m | €147.7m |
| Net income | €314.5m | €614.6m | €623.1m | €465.9m | €162.2m | €129.0m | €144.8m | €141.1m | €155.0m | €34.2m |
| Diluted earnings per share | 2.15 | 4.27 | 4.42 | 3.40 | 1.20 | 0.92 | 1.01 | 0.99 | 1.08 | 0.29 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €11.43bn | €10.67bn | €8.04bn | €6.98bn | €5.09bn | €4.00bn | €4.16bn | €3.34bn | €3.23bn | €3.11bn |
| Cash and short-term investments | €2.07bn | €1.19bn | €933.5m | €1.05bn | €602.7m | €493.2m | €712.6m | €208.1m | €162.1m | €198.8m |
| Total liabilities | €8.32bn | €7.58bn | €5.34bn | €4.76bn | €3.47bn | €2.41bn | €2.52bn | €1.78bn | €1.79bn | €1.82bn |
| Debt | €5.09bn | €4.26bn | €3.11bn | €1.96bn | €1.41bn | €1.03bn | €1.13bn | €598.4m | €730.9m | €815.8m |
| Shareholders' equity | €3.01bn | €2.99bn | €2.61bn | €2.13bn | €1.54bn | €1.52bn | €1.58bn | €1.51bn | €1.38bn | €988.9m |
| Shares outstanding | 146m | 144m | 141m | 137m | 136m | 140m | 143m | 143m | 143m | 117m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €445.9m | €409.0m | €156.0m | €888.7m | €219.9m | €248.6m | €243.8m | €161.9m | €214.7m | €48.0m |
| Capital spending | −€687.5m | −€801.3m | −€1.05bn | −€715.7m | −€365.1m | −€136.6m | −€116.8m | −€75.7m | −€121.4m | −€82.6m |
| Free cash flow | −€241.7m | −€392.2m | −€898.3m | €172.9m | −€145.2m | €112.0m | €127.0m | €86.2m | €93.3m | −€34.6m |
| Dividends paid | −€214.1m | −€206.4m | −€165.2m | −€57.9m | −€51.8m | −€49.6m | −€52.0m | −€45.9m | −€5.1m | −€3.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €3.99bn | €1.99bn | €3.50bn | €1.75bn | €1.80bn | €1.80bn | €1.60bn | €1.60bn |
| Gross profit | €507.4m | €254.2m | €104.4m | €59.2m | €180.4m | €180.0m | €307.1m | €307.1m |
| Operating income | €432.3m | €222.5m | €15.9m | €281.3m | €142.6m | €142.3m | €458.6m | €458.7m |
| Net income | €312.8m | €156.4m | €60.7m | €30.4m | €126.9m | €126.6m | €166.3m | €166.3m |
| Diluted earnings per share | 2.18 | 1.09 | 0.42 | 0.21 | 0.87 | 0.87 | 1.15 | 1.15 |
| Cash from operations | €739.0m | €367.0m | €441.0m | €217.0m | €17.0m | €5.0m | €230.0m | €230.0m |
| Capital spending | −€198.0m | −€99.0m | −€45.0m | −€22.0m | −€578.0m | −€290.0m | −€171.0m | −€172.0m |
| Free cash flow | €541.0m | €268.0m | €396.0m | €195.0m | −€561.0m | −€285.0m | €59.0m | €58.0m |
| Total assets | €12.97bn | €12.97bn | €11.43bn | €11.43bn | €10.61bn | €10.64bn | €10.67bn | €10.67bn |
| Cash and short-term investments | €2.59bn | €2.59bn | €1.75bn | €1.75bn | €1.31bn | €1.32bn | €1.15bn | €1.41bn |
| Debt | €5.24bn | €890.4m | €4.89bn | €1.00bn | €354.0m | €353.2m | €663.1m | €686.7m |
| Shareholders' equity | €3.17bn | €3.17bn | €3.01bn | €3.01bn | €3.12bn | €3.13bn | €2.99bn | €2.99bn |
Financial ratios
Data as of 16 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 6.5% | 17.9% | 17.8% | 15.3% | 13.7% | 17.9% | — | — |
| Operating margin | 7.7% | 15.6% | 15.9% | 10.9% | 10.5% | 12.2% | — | — |
| Net margin | 4.4% | 10.8% | 11.3% | 7.4% | 6.1% | 6.8% | — | — |
| Return on equity | 10.4% | 20.5% | 23.9% | 21.9% | 10.5% | 8.5% | — | — |
| Return on assets | 2.8% | 5.8% | 7.7% | 6.7% | 3.2% | 3.2% | — | — |
| Free cash flow yield | 15.9% | 17.2% | 17.6% | 24.0% | 8.8% | 5.6% | — | — |
| Revenue growth | 25.1% | 3.5% | -12.9% | 136.8% | 40.2% | -15.7% | — | — |
| Earnings growth | -48.8% | -1.4% | 33.7% | 187.3% | 25.7% | -10.9% | — | — |
| Current ratio | 1.86x | 1.84x | 1.63x | 1.65x | 1.62x | 1.89x | — | — |
| Debt to equity | 1.62x | 1.36x | 1.13x | 0.89x | 0.05x | 0.05x | — | — |
| Equity ratio | 26.4% | 28.0% | 32.4% | 30.5% | 30.3% | 38.0% | — | — |
| Interest coverage | 3.35x | 6.44x | 10.00x | 12.23x | — | — | — | — |
| R&D as a share of sales | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Buybacks as a share of market value | -1.3% | -2.1% | -2.9% | -1.1% | 3.0% | 2.3% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 4.1% | 30.2% | 17.8% |
| Operating income | -9.9% | 20.2% | 11.3% |
| Net income | -12.3% | 19.5% | 20.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 11.6% | 13.9% | 14.2% | 15.0% |
| Operating margin | 11.2% | 12.5% | 12.3% | 12.4% |
| Net margin | 7.3% | 8.2% | 7.9% | 7.6% |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | 20.5 |
| Price to sales | 0.9 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.